MA
NUVB icon

MYDA Advisors’s Nuvation Bio NUVB Stock Holding History

MYDA Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20,000
Closed -$170K – 249
2021
Q4 		$170K Sell
20,000
-20,000
-50% -$184K 0.05% 207
2021
Q3 		$398K Sell
40,000
-6,000
-13% -$54.4K 0.11% 177
2021
Q2 		$428K Sell
46,000
-34,000
-43% -$388K 0.11% 200
2021
Q1 		$836K Buy
+80,000
New +$894K 0.23% 134

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MYDA Advisors's NUVB Position: Q1 2022 in Review

MYDA Advisors sold out of Nuvation Bio (NUVB) in Q1 2022, closing a stake of 20,000 shares — an estimated $170K sold.

MYDA Advisors first reported a position in NUVB in Q1 2021 and held it in 4 quarters. The position peaked at $836K in Q1 2021. 117 funds tracked by Wall St. Rank hold NUVB as of Q1 2022.

  • MYDA Advisors reported no remaining Nuvation Bio position as of Q1 2022 after selling out during the quarter.
  • MYDA Advisors sold 20,000 Nuvation Bio shares in Q1 2022, an estimated $170K.
  • MYDA Advisors first reported a position in Nuvation Bio in Q1 2021 and held it in 4 quarters.
  • MYDA Advisors's Nuvation Bio position peaked at $836K in Q1 2021.
  • 117 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2022.

Based on MYDA Advisors's 13F filing for Q1 2022, filed 13 May 2022.